American Society for Microbiology, Journal of Clinical Microbiology, 8(57), 2019
DOI: 10.1128/jcm.00762-19
Full text: Unavailable
Chimeric T. cruzi antigens have been proposed as a diagnostic tool for chronic Chagas disease (CD) in both settings where Chagas disease is endemic and those where it is not endemic. Antibody response varies in accordance to each T. cruzi strain, presenting challenges to the use of antigens lacking demonstrated cross-reactivity with Leishmania spp.